Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations. CELVAPAN, the brand name for the company’s A/H1N1 pandemic influenza vaccine, is made using Baxter’s proprietary Vero cell culture technology.

Baxter plans to deliver initial quantities of CELVAPAN to national public health authorities that have pandemic agreements with the company. These health authorities placed orders for the vaccine following the World Health Organization’s (WHO) elevation of the pandemic alert level to phase 6 and declaration of a pandemic.

Baxter’s proprietary Vero cell production technology is meeting the company’s expectations to rapidly produce a vaccine in response to a pandemic. CELVAPAN was developed and commercially produced using this process within 12 weeks of receiving the A/H1N1 virus strain, which represents an innovation in vaccine production.

“We are pleased with our company’s ability to meet its expected timelines in developing and producing CELVAPAN,” said Joy Amundson, corporate vice president and president of Baxter BioScience. “This is an encouraging validation of our science, our Vero cell vaccine technology and the teamwork at Baxter in meeting this important milestone to help address an urgent public health issue.”



•  Canada to order 50.4 million H1N1 vaccine doses (Link)

•  Dog possiblly responsible for plauge (translated) (Link)

•  Egypt to buy five million doses of H1N1 vaccine (Link)

•  First swine influenza case found in Finnish Defence Forces (Link)

•  Swine flu patient admitted in critical condition in Pune (Link)
•  19 new swine flu cases in India, total 616  (Link)
•  Goa: Bus passengers from Pune to be screened  (Link)
•  Three doctors test positive for swine flu in Delhi (Link)

•  Bird Flu Suspect Taken to Hospital (translated) (Link)
•  KN, 16, A Bird Flu Suspect (translated) (Link)

•  Mexico swine flu toll up to 149 (Link)

•  Four new H1N1 cases confirmed in Morocco (Link)

South Africa
•  S. Africa: Swine flu panic spreads across city (Link)
•  KZN ‘swine flu’ death unconfirmed (Link)

United Kingdom
•  Ireland: Swine flu numbers stabilise ahead of likely winter surge (Link)
•  Leeds: Swine flu helpline cuts numbers attending A&E (Link)
•  Swine flu girl ‘was misdiagnosed’ (Link)
•  First swine flu death in Republic of Ireland (Link)
•  Ireland: Swine flu victim contracted virus in community (Link)

United States
•  CA: Sixth swine flu death reported in Contra Costa County (Link)
•  KS: New Strain Of Swine Flu Infects Riley County Child (Link)
•  CA: Jail inmates quarantined in swine flu outbreak  (Link)
•  FL: Family Speaks Out After H1N1 Death (Link)
•  FL: Parents Alerted Of Likely H1N1 Cases (Link)
•  First H1N1 Flu death reported in MT (Link)
•  CA: Seven West Valley Detention Center inmates have H1N1 virus; 48 quarantined (Link)
•  U.S. Discourages Quick School Closure (Link)
•  Florida A/H1N1 flu deaths double to 41 in 2 weeks  (Link)
•  OR: Lane County sees first swine flu fatality (Link)

•  Vietnam confirms 39 new A/H1N1 cases (Link)

•  Baxter Completes Production Of First Commercial Batches Of A/H1N1 Pandemic Vaccine  (Link)
•  Swine Flu Panic Hits the Hajj (Link)
•  5 countries carrying out trial vaccine of H1N1 (translated) (Link)

•  Research Assesses Use of Tamiflu, Relenza to Prevent Flu (Link)

•  Effect Measure by revere – Swine flu this fall: turbulence ahead (Link)